Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Exagen Inc. (XGN) to participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, offering one-on-one meetings with investors and a fireside chat on March 20, 2024.
03/08/2024 - 09:00 AM
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, which takes place virtually March 19-20, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will participate in one-on-one meetings with investors and a fireside chat on Wednesday, March 20, at 1:30 PM ET.
About Exagen Inc. Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact: ir@exagen.com
When will Exagen Inc. (XGN) participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?
Exagen Inc. (XGN) will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 19-20, 2024.
Who will be representing Exagen Inc. (XGN) at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?
John Aballi, President and CEO, and Kamal Adawi, CFO, will represent Exagen Inc. (XGN) at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum.
What is the timing of the fireside chat involving Exagen Inc. (XGN) at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?
The fireside chat involving Exagen Inc. (XGN) will take place on Wednesday, March 20, at 1:30 PM ET during the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum.
XGN Rankings
#4255 Ranked by Stock Gains
XGN Stock Data
Industry
Dental Laboratories
Sector
Manufacturing
Tags
Health Services, Medical/Nursing Services, Manufacturing, Dental Laboratories
Country
US
City
Vista
About XGN
exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.
